CJC-1295 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-09-10. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Heroin is produced from opium, which is regulated differently around the world. Unlike coca leaves in Peru—handled exclusively by the state monopoly, the National Coca Company (ENACO)—there is no state company dedicated to the commercialization of opium and its derivatives. While international treaties—such as the Single Convention on Narcotic Drugs (1961)—require strict state control or monopoly over the legal production and commercialization of opium for medical and scientific purposes, in practice, only a few countries maintain such a state monopoly today. Notably, India operates a state monopoly through the Government Opium and Alkaloid Factories (GOAF), also known as Opium and Alkaloid Works, which is responsible for processing raw opium into alkaloids for the pharmaceutical industry and managing the legal opium trade for medical and scientific use. Legal opium production in India, as well as in countries such as Turkey, Australia, France, Japan, and the UK, supplies licensed pharmaceutical manufacturers under close supervision to prevent diversion to illicit markets.
=== Europe === Lancaster AMS-UK for trace actinides and radiocarbon at Lancaster University, England Vilnius Radiocarbon AMS dating laboratory in Vilnius, Lithuania Centre for Isotope Research on Cultural and Environmental heritage (CIRCE) [1], Mathematics and Physics Department [2], Università degli Studi della Campania "Luigi Vanvitelli", Caserta, Italy CEREGE in Aix en Provence, France LMC14 Laboratoire de mesure du carbone 14, at LSCE, Saclay, France LSCE-ECHoMICADAS, at LSCE, Gif-sur-Yvette, France 14Chrono Centre for Climate, the Environment, and Chronology Queen's University Belfast, Northern Ireland Bristol Radiocarbon Accelerator Mass Spectrometer at University of Bristol, England RICH, Royal Institute for Cultural heritage, Brussels, Belgium CologneAMS at University of Cologne, Germany Hertelendi Laboratory of Environmental Studies at ATOMKI, Debrecen, Hungary DREAMS at Dresden, Germany Centre for Isotope Research Rijksuniversiteit Groningen, The Netherlands Beta Analytic Europe in London, England Tandem Laboratory at Uppsala University in Uppsala, Sweden Lund Accelerator Mass Spectrometry Facility at Lund University, Sweden RoAMS Laboratory of the "Horia Hulubei" National Institute for Physics and Nuclear Engineering Măgurele, Romania AMS at the Maier-Leibnitz-Laboratory joint facility of LMU Munich and Technical University of Munich, Germany Oxford Radiocarbon Accelerator Unit, University of Oxford, United Kingdom Poznan Radiocarbon Laboratory, Poland Centre for Dating and Diagnostics (CEDAD), University of Salento, Italy [3] Centro Nacional de Aceleradores, CNA University of Sevilla, Spain NERC Recognised Accelerator Mass Spectrometer at SUERC, Scotland Vienna Environmental Research Accelerator at the University of Vienna, Austria Ion Beam Physics Laboratory of the ETH Zurich and the Paul Scherrer Institute, Switzerland National 1MV AMS Laboratory, TÜBİTAK Marmara Research Center Turkey Nuclear Physics Institute, The Czech Academy of Sciences, Czech Republic
After Reagan's military buildup, the Soviet Union did not respond by further building its military, because the enormous military expenses, along with inefficient planned manufacturing and collectivized agriculture, were already a heavy burden for the Soviet economy. At the same time, Saudi Arabia increased oil production, even as other non-OPEC nations were increasing production. These developments contributed to the 1980s oil glut, which affected the Soviet Union as oil was the main source of Soviet export revenues. Issues with command economics, oil price decreases and large military expenditures gradually brought the Soviet economy to stagnation.
Sources: en.wikipedia.org
=== Weather === Some evidence suggests sunnier climates do not predict happiness. In one study, both Californians and Midwesterners expected the former's happiness ratings to be higher due to a sunnier environment. In fact, the Californian and Midwestern happiness ratings did not show a significant difference. Other research has found that temperature, wind power, sunlight, precipitation and air temperature has a small impact on mood, but some people appear to be affected in a large way (but it's not 5 factor personality). A study of Dutch teenagers identified that the effect of weather on mood depends on whether they were Summer lovers, summer haters, rain haters and unaffected by weather. Other researchers say the necessary minimum daily dose of sunlight is as little as 30 minutes. That is not to say weather is never a factor for happiness. Perhaps the changing norms of sunlight cause seasonal affective disorder, which undermines level of happiness.
== Ecology == Viola species are used as food plants by the larvae of some Lepidoptera species, including the giant leopard moth, large yellow underwing, lesser broad-bordered yellow underwing, high brown fritillary, small pearl-bordered fritillary, pearl-bordered fritillary, regal fritillary, cardinal, and Setaceous Hebrew character. The larvae of many fritillary butterfly species use violets as an obligate host plant, although these butterflies do not always oviposit directly onto violets. While the ecology of this genera is extremely diverse, violets are mainly pollinated by members within the orders Diptera and Hymenoptera. Showy flowers are produced in early spring, and clonal cleistogamous flowers are produced from late spring until the end of the growing season under favorable conditions. Cleistogamy allows plants to produce offspring year round and have more chances for establishment. This system is especially important in violets, as these plants are often weak competitors for pollination due to their small size. Many violet species exhibit two modes of seed dispersal. Once seed capsules have matured, seeds are dispelled around the plant through explosive dehiscence. Viola pedata seeds have been reported being dispersed distances of up to 5 meters away from the parent plant. Often, seeds are then further dispersed by ants through a process called myrmecochory. Violets whose seeds are dispersed this way have specialized structures on the exterior of the seeds called elaiosomes.
=== RNAP sequencing === This method is based on use of RNA polymerase (RNAP), which is attached to a polystyrene bead. One end of DNA to be sequenced is attached to another bead, with both beads being placed in optical traps. RNAP motion during transcription brings the beads in closer and their relative distance changes, which can then be recorded at a single nucleotide resolution. The sequence is deduced based on the four readouts with lowered concentrations of each of the four nucleotide types, similarly to the Sanger method. A comparison is made between regions and sequence information is deduced by comparing the known sequence regions to the unknown sequence regions.
HClO ⇌ ClO− + H+ Salts of hypochlorous acid are called hypochlorites. One of the best-known hypochlorites is NaClO, the active ingredient in bleach. HClO is a stronger oxidant than chlorine under standard conditions.
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.